Tagged with EALTH

France Jean-Luc Belingard, president of FEFIS (Fédération Française des Industries de Santé – French Federation of the Health Industry), explains his role following up on the implementation of the CSIS (Conseil stratégique des industries de santé – Strategic council of the healthcare industry) and speaks out about the competitiveness of the…

UK The two Big Pharma giants today announced the merger between their consumer healthcare businesses, with the joint venture (JV) set to become the global market leader in over-the-counter (OTC) products with a market share of 7.3 percent.   This move will see GSK effectively split into two separate businesses –…

Korea Yong-Ik Kim, president of Korea’s National Health Insurance Service (NHIS), provides an insight into the implementation of the upcoming MoonCare reforms, the government’s strategy to ensure the expansion of coverage is achieved sustainably, and the task of balancing affordable drug prices and encouraging innovation.   What are the main challenges…

Turkey The Minister of Health of the Republic of Turkey, Dr Fahrettin Koca, provides an overview of the current state of the Turkish healthcare ecosystem, highlighting its opportunities and challenges. He emphasises Turkey’s ambition to become a global leader in medical manufacturing as well as a popular target for health tourism.…

Malaysia Click here to download the Healthcare & Life Sciences Review Malaysia 2018. After recent elections conducted in May 2018 saw Mahathir Mohamad returning as Prime Minister after 15 years to seal a historic victory, Malaysia is again back on its feet. Bolstered by well-established institutions, a fully-functional IP framework and strong…

IFPMA On Universal Health Coverage day, the Director General of IFPMA (the International Federation of Pharmaceutical Manufacturers and Associations) explains UHC and how the biopharmaceutical industry is part of the solution.   Our industry is much more than a supplier of medicines and vaccines and is increasingly pioneering new ways to overcome…

France In an exclusive interview, Yves L’Epine, president of G5 Santé and CEO of Guerbet, offers his insider take on the business climate in French healthcare and the potential for France to reclaim its position as a global industry power.   Our members are committed to finding the “healthcare integrated solutions…

Malaysia Rashidah Ibrahim, executive director of Malaysian Vaccines & Pharmaceuticals (MVP), tells the story of MVP as the sole animal vaccines manufacturer in Malaysia. She also explains how important animal health is for human health and what plans she has set for the company moving forward.   Animal and human health…

Turkey Sule Mene, co-founder, president and CEO of Mene Health Group, shares with PharmaBoardroom the journey of her company starting as the first government-approved CRO of Turkey, its parallel growth alongside the increasingly prominent clinical trial environment of the country, evolution to becoming a value chain group of companies in clinical…

Malaysia Wong Kin Sang, country manager of Lundbeck Malaysia, walks us through the mental health issues’ perception in Malaysia and the important work Lundbeck has done to bring more awareness to healthcare professionals and patients in the country. He also highlights his future plans for the affiliate to bring more innovative…

Spain Although death rates due to cardiovascular diseases in Spain are among the lowest in the EU, they represent the main cause of death in Spain, accounting for 30% of all deaths in 2014 (33% of deaths among women and 27% among men). Cancer is the second most important cause of…

France Stéphane Roques, CEO of Medicen, the health care cluster for the Paris region, discusses his vision for Medicen and the changes he has made during his first few months in the tole. He highlights the need for domestic and European collaboration to be able to compete against clusters in the…